Guest guest Posted June 21, 2010 Report Share Posted June 21, 2010 Keep in mind, Clarence used to be the atty for MonSatan! What I CAN'T understand, is how the people who created the movie, Food, Inc., are HAPPY with this decision! http://www.nytimes.com/2010/06/22/business/22bizcourt.html?src=busln Justices Back Monsanto on Biotech Seed Planting Bob Brawdy/The Tri-City Herald, via Associated Press The decision was a victory for Monsanto and othersin the agricultural biotechnology industry. Above, an alfalfa field inPasco, Wash. By ANDREW POLLACK Published: June 21, 2010 Facebook Twitter Recommend Sign In to E-Mail Print Reprints ShareClose Linkedin Digg Mixx MySpace Buzz Permalink In its first-ever ruling on genetically modified crops, the Supreme Court on Monday overturned a lower court’s ban on the planting of alfalfa seeds engineered to resist Monsanto’s Roundup herbicide. Add to Portfolio Monsanto Co Go to your Portfolio » The decision was a victory for Monsanto and others in the agriculturalbiotechnology industry, with potential implications for other cases,like one involving genetically engineered sugar beets. But in practice the decision is not likely to measurably speed up theresumption of planting of the genetically engineered alfalfa. A federal district judge in San Francisco had ruled in 2007 that theAgriculture Department had approved the genetically engineered alfalfafor commercial planting without adequately considering the possibleenvironment impact, as required by federal law. The judge vacatedapproval, known as deregulation of the crop, and also imposed anationwide ban on planting those seeds. The ban was later upheld onappeal. But the Supreme Court, in a 7-to-1 decision, said the lower court judgehad gone too far, ruling that the national ban prevented theAgriculture Department from considering a partial approval. Thatavenue, the court said, would have allowed some of the alfalfa to begrown under certain conditions; for example, isolating it fromconventional alfalfa. “The district court barred the agency from pursuing any deregulation —no matter how limited the geographic area in which planting of RRAwould be allowed,†Justice A. Alito Jr. wrote in the opinion, referring to Roundup Ready alfalfa. Justice s was the lone dissenter. Justice G. Breyer did not take part because his brother, District Judge Breyer, had issued the original decision. Because the Supreme Court left in place the lower court’s rejection ofapproving the crop, the Agriculture Department must either fully orpartly approve it before growing can resume. “I think the practical impact is nil,†said A. Kimbrell of theCenter for Food Safety, a Washington advocacy group that was part of acoalition of environmental groups and organic and conventional alfalfafarmers who had challenged the crop’s approval. The Agriculture Department said Monday that it was on track to completeits environmental impact statement and approve the crop in time fornext spring’s planting. Speeding up planting beyond that could only occur if the agency pursuesa partial approval while finishing its environmental assessment. Butgetting partial approval in time for this fall’s planting season —beginning in two months — might be difficult. Still, F. Snively, Monsanto’s general counsel, called thedecision a significant victory. “Monsanto and farmers in the UnitedStates are thrilled with this decision, which is far-reaching in itslook at the regulatory framework that should govern biotech crops,†Mr.Snively told reporters in a conference call. The Supreme Court’s ruling could affect a similar case, also brought bythe Center for Food Safety, involving Roundup Ready sugar beets. In that case, a different federal judge in San Francisco ruled lastSeptember that the Agriculture Department had failed to adequatelyassess the environmental impact. Planting has continued, however, because the judge, S. White,has not yet ruled on a remedy. A hearing on the matter is scheduled forJuly 9. The Supreme Court’s decision makes it highly unlikely that hewill issue a blanket ban on the growing of the genetically engineeredbeets. The decision could also sway environmental law in general. Organizations like the National Association of Home Builders and the American Petroleum Institutehad filed friend-of-the-court briefs supporting Monsanto, whileenvironmental groups as well as the states of California, Oregon andMassachusetts had weighed in on the side of the Center for Food Safety. Mr. Snively of Monsanto said the decision made it clear that courtsmust meet the same strict test in granting injunctions in environmentalcases as in other cases. But iel S. W. Lawrence, an attorney forthe Natural Resources Defense Council,said the decision also contained wording that would make it easier insome instances for lawsuits to be filed in cases of possibleenvironmental dangers. Roundup Ready alfalfa and sugar beets were the newest additions toMonsanto’s extremely successful lines of Roundup Ready soybeans, cornsand cotton. The crops contain a bacterial gene that allows them to withstandspraying with Roundup or its generic equivalents, known as glyphosate.That allows farmers to spray their fields to kill weeds while leavingthe crop intact, making weed control easy. The environmental groups and others had said that the foreign genemight spread to organic or conventional nongenetically engineeredcrops, hurting sales of organic farmers or exports to countries likeJapan that did not want genetically engineered varieties. Court Upholds Verdict The Supreme Court rejected Pfizer’sappeal of a verdict for an Arkansas woman, Donna Scroggin, who blamedthe company’s menopause drugs for her breast cancer, leaving intact a$2.7 million award that may grow with punitive damages. The justices let stand on Monday a lower court decision upholding thataward, which was the first federal verdict against Pfizer’s Wyeth unit over its Prempro hormone-replacement treatment. The appeal by Wyeth and Pfizer’s Upjohn unit sought to leverage adifferent part of the appeals court ruling ordering a new trial onpunitive damages, which a jury had set at $27 million. Pfizer arguedthat the new trial should cover all aspects of the case, including thejury’s finding that the drugs had helped cause Ms. Scroggin’s cancer. A version of this article appeared in print on June 22, 2010, on page B5 of the New York edition. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.